Trial intelligence / Profile preview

Auricular Acupoint Embedding for Renal Colic

NCT06978816Recruiting

Start
Jun 2025
Primary completion
Jun 2026
Countries
1
01

Overview

Randomised, single-blind trial (2 arms). Primary endpoint: Response rate of Visual Analog Scale (VAS) reduction at 60 months. Started Jun 2025; status: recruiting.

Beyond the preview

Go deeper on NCT06978816.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06978816.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call